We Can Quit2 (WCQ2): a community-based programme to help women living in disadvantaged areas of Ireland to stop smoking

Not Applicable

Completed

• Conditions: Smoking cessation; Mental and Behavioural Disorders

• Registration Number: ISRCTN74721694
• Lead Sponsor: Trinity Research & Innovation, Trinity College Dublin

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31788324/ protocol (added 27/11/2020) 2019 Abstract results in http://dx.doi.org/10.1136/jech-2019-SSMabstracts.193 abstract on the recruitment strategies and lessons learned from the WCQ2 trial, presented at the Society for Social Medicine annual meeting : (added 04/01/2021) 2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32104776/ systematic review protocol for community smoking cessation trials in low-income women (added 04/01/2021) 2020 Abstract results in http://dx.doi.org/10.1136/jech-2020-SSMabstracts.13 abstract on preliminary findings of the WCQ2 trial, presented at the SSM-PH Annual Scientific Meeting 2020 (added 16/11/2021) 2021 Abstract results in http://dx.doi.org/10.1136/jech-2021-SSMabstracts.133 abstract on results of the trial knowledge exchange and dissemination strategy of the WCQ2 trial, presented at SSM-PH Annual Scientific Meeting 2021 (added 16/11/2021) 2021 Abstract results in https://doi.org/10.1093/eurpub/ckab165.343 abstract on rresults of the trial process evaluation of the WCQ2 trial, presented at 14th European Public Health (EPH) Conference 2021 (added 16/11/2021) 2019 Abstract results in https://doi.org/10.1093/eurpub/ckz185.646 abstract on the preliminary findings from the WCQ2 trial, presented at the 11th EU Public Health Association (EUPHA) Meeting 2020 (added 16/11/2021) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35078530/ Retrospective evaluation of the WCQ2 pilot trial design (added 27/01/2022) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35206521/ Knowledge Exchange and Evaluation (added 14/06/2022) 2021 Preprint results in https://doi.org/10.21203/rs.3.rs-1039705/v1 Accompanying process evaluation results (added 14/06/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34939119/ (added 14/06/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35948970/ Process evaluation (added 12/08/2022) 2021 Results article in https://doi.org/10.1093/ntr/ntab242 (added 27/09/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-29
• Study Completion: 2019-08-26
• Last Update Posted: 10 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 208

Inclusion Criteria

1. Female
2. Aged 18 or over
3. English speaker
4. Self-reported as a daily smoker with an interest in quitting
5. Deemed to live/work within easy travel distance of the trial catchment areas
Women taking Nicotine Replacement Therapy (NRT) or who are have been prescribed bupropion/varenicline by the doctor at time of recruitment are eligible to take part, as are women using e-cigarettes.

Exclusion Criteria

1. Pregnant or planning a pregnancy in the near future
2. Enrolled in another smoking cessation study
3. Cannot travel to location of programme delivery
4. Do not have the capacity to give informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified